0 0 Oxford Women's Health Limited 14019107 false 2023-05-01 2024-04-30 2024-04-30 The principal activity of the company is to provide specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true true 14019107 2023-05-01 2024-04-30 14019107 2024-04-30 14019107 bus:OrdinaryShareClass1 2024-04-30 14019107 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-04-30 14019107 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-04-30 14019107 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2024-04-30 14019107 core:CurrentFinancialInstruments 2024-04-30 14019107 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 14019107 core:Non-currentFinancialInstruments core:AfterOneYear 2024-04-30 14019107 core:MotorVehicles 2024-04-30 14019107 bus:SmallEntities 2023-05-01 2024-04-30 14019107 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 14019107 bus:FilletedAccounts 2023-05-01 2024-04-30 14019107 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 14019107 bus:RegisteredOffice 2023-05-01 2024-04-30 14019107 bus:Director1 2023-05-01 2024-04-30 14019107 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 14019107 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14019107 core:MotorVehicles 2023-05-01 2024-04-30 14019107 countries:EnglandWales 2023-05-01 2024-04-30 14019107 2023-04-30 14019107 core:MotorVehicles 2023-04-30 14019107 2022-04-01 2023-04-30 14019107 2023-04-30 14019107 bus:OrdinaryShareClass1 2023-04-30 14019107 core:HirePurchaseContracts core:CurrentFinancialInstruments 2023-04-30 14019107 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2023-04-30 14019107 core:CurrentFinancialInstruments 2023-04-30 14019107 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 14019107 core:Non-currentFinancialInstruments core:AfterOneYear 2023-04-30 14019107 core:MotorVehicles 2023-04-30 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 14019107

Oxford Women's Health Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2024

 

Oxford Women's Health Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 6

 

Oxford Women's Health Limited

(Registration number: 14019107)
Balance Sheet as at 30 April 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

45,282

61,748

Other financial assets

5

50,000

-

 

95,282

61,748

Current assets

 

Debtors

6

-

36,693

Cash at bank and in hand

 

115,060

85,285

 

115,060

121,978

Creditors: Amounts falling due within one year

7

(116,760)

(115,080)

Net current (liabilities)/assets

 

(1,700)

6,898

Total assets less current liabilities

 

93,582

68,646

Creditors: Amounts falling due after more than one year

7

(40,073)

(43,568)

Net assets

 

53,509

25,078

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

53,409

24,978

Shareholders' funds

 

53,509

25,078

For the financial year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 17 January 2025 and signed on its behalf by:
 

.........................................
Dr Christian Malte Becker
Director

 

Oxford Women's Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
30 St Giles'
Oxford
OX1 3LE

These financial statements were authorised for issue by the Board on 17 January 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Oxford Women's Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Oxford Women's Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 0).

 

Oxford Women's Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

4

Tangible assets

Motor vehicles
 £

Total
£

Cost or valuation

At 1 May 2023

65,865

65,865

At 30 April 2024

65,865

65,865

Depreciation

At 1 May 2023

4,117

4,117

Charge for the year

16,466

16,466

At 30 April 2024

20,583

20,583

Carrying amount

At 30 April 2024

45,282

45,282

At 30 April 2023

61,748

61,748

5

Other financial assets (current and non-current)

Financial assets at cost less impairment
£

Total
£

Non-current financial assets

Cost or valuation

Additions

50,000

50,000

At 30 April 2024

50,000

50,000

Impairment

Carrying amount

At 30 April 2024

50,000

50,000

6

Debtors

2024
£

2023
£

Trade debtors

-

36,133

Prepayments

-

560

-

36,693

 

Oxford Women's Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

7

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

9

5,896

8,296

Taxation and social security

 

33,259

25,569

Other creditors

 

77,605

81,215

 

116,760

115,080

Creditors include net obligations under finance lease and hire purchase contracts which are secured of £5,896 (2023 - £8,296).

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

9

40,073

43,568

Creditors include net obligations under finance lease and hire purchase contracts which are secured of £40,073 (2023 - £43,568).

8

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       

9

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Hire purchase contracts

40,073

43,568

Current loans and borrowings

2024
£

2023
£

Hire purchase contracts

5,896

8,296